help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Komesaroff, P. A.
Right arrow Articles by Fuller, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komesaroff, P. A.
Right arrow Articles by Fuller, P. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Journal of Clinical Endocrinology & Metabolism, Vol 79, 27-31, Copyright © 1994 by Endocrine Society


ARTICLES

Pseudohypoaldosteronism: molecular characterization of the mineralocorticoid receptor

PA Komesaroff, K Verity and PJ Fuller
Baker Medical Research Institute, Prahran, Victoria, Australia.

Mineralocorticoid resistance (pseudohypoaldosteronism) is a rare condition first described in 1958 and associated with failure to thrive, salt wasting, and dehydration in infancy. In the index case it has previously been shown that binding of aldosterone to mineralocorticoid receptors in peripheral blood lymphocytes is absent; here, we report results of the molecular characterization of the mineralocorticoid receptor in this patient. Genomic DNA extracted from peripheral blood lymphocytes was subjected to Southern blot analysis after digestion with various restriction enzymes. There was no evidence of a major gene rearrangement or deletion. Oligonucleotide primers were designed on the basis of the published human complementary DNA sequence to cover the entire open reading frame of the mineralocorticoid receptor (MR). Total messenger ribonucleic acid (RNA) from lymphocytes was subjected to reverse transcription and amplification using the reverse transcriptase-polymerase chain reaction; the resulting fragments were then purified, subcloned, and sequenced. The patient showed no abnormality in the complementary DNA sequence corresponding to the open reading frame of the MR molecule compared with the published sequence. In addition, semiquantitative assessment of the patient's MR messenger RNA based on the reverse transcriptase- polymerase chain reaction technique suggested that he was producing MR RNA in roughly normal quantities. The mechanism of mineralocorticoid resistance in this case, therefore, remains uncertain, and the possibility must be considered that the underlying abnormality is not in the MR gene, but in an independent gene acting through yet to be characterized processes.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A.-M. Nystrom, M.-L. Bondeson, N. Skanke, J. Martensson, B. Stromberg, J. Gustafsson, and G. Anneren
A Novel Nonsense Mutation of the Mineralocorticoid Receptor Gene in a Swedish Family with Pseudohypoaldosteronism Type I (PHA1)
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 227 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Viemann, M. Peter, J. P. López-Siguero, G. Simic-Schleicher, and W. G. Sippell
Evidence for Genetic Heterogeneity of Pseudohypoaldosteronism Type 1: Identification of a Novel Mutation in the Human Mineralocorticoid Receptor in one Sporadic Case and No Mutations in Two Autosomal Dominant Kindreds
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2056 - 2059.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Arai, K. Zachman, T. Shibasaki, and G. P. Chrousos
Polymorphisms of Amiloride-Sensitive Sodium Channel Subunits in Five Sporadic Cases of Pseudohypoaldosteronism: Do They Have Pathologic Potential?
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2434 - 2437.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M.-C. Zennaro, N. Farman, J.-P. Bonvalet, and M. Lombes
Tissue-Specific Expression of {alpha} and {beta} Messenger Ribonucleic Acid Isoforms of the Human Mineralocorticoid Receptor in Normal and Pathological States
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1345 - 1352.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Gamarra, G. Simic-Schleicher, R. M. Huber, A. Ulsenheimer, P. C. Scriba, U. Kuhnle, and M. Wehling
Impaired Rapid Mineralocorticoid Action on Free Intracellular Calcium in Pseudohypoaldosteronism
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 831 - 834.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kralli and K. R. Yamamoto
An FK506-sensitive Transporter Selectively Decreases Intracellular Levels and Potency of Steroid Hormones
J. Biol. Chem., July 19, 1996; 271(29): 17152 - 17156.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-C. Zennaro, M.-C. Keightley, Y. Kotelevtsev, G. S. Conway, F. Soubrier, and , P. J. Fuller
Human Mineralocorticoid Receptor Genomic Structure and Identification of Expressed Isoforms
J. Biol. Chem., September 8, 1995; 270(36): 21016 - 21020.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society